tci Medicare Compliance & Reimbursement - 2011 Issue 22

Industry Notes: CMS Adds 16 Lab Tests to CLIA-Waived Status

Part B practices will benefit from three new tests that you'll be able to report as "CLIA-waived," thanks to an Oct. 21 CMS transmittal on the matter. According to MLN Matters article 2321, CMS will now consider these tests CLIA-waived. You'll have to append Modifier QW (CLIA-waived test) to these codes, which include the following, among others: 81003 -- Germaine Laboratories Inc. AimStrip Urine Analyzer and Mediwatch urinewatch Urine Analyzer G0434 -- UCP Biosciences, Inc. Drug Screening Test Cups, Diagnostic Test Group Clarity Multiple Drug Screen Cups, and Jant Pharmacal Accutest Drug of Abuse Urine Cup Test To...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.